El Dorado News-Times

Indians cautioned about vaccinatio­ns

Producer warns of severe reactions

- SHEIKH SAALIQ Informatio­n for this article was contribute­d by Marcelo Silva De Sousa, Fernando Crispim and staff members of The Associated Press.

NEW DELHI — India’s homegrown coronaviru­s vaccine developer Bharat Biotech on Tuesday warned people with weak immunity and other medical conditions including allergies, fever or a bleeding disorder to consult a doctor before getting the shot — and if possible avoid the vaccine.

The company said those receiving vaccinatio­ns should disclose their medical condition, medicines they are taking and any history of allergies. It said severe allergic reactions among vaccine recipients may include difficulty breathing, swelling of the face and throat, rapid heartbeat, body rashes, dizziness and weakness.

The vaccine developed by Bharat Biotech ran into controvers­y after the Indian government allowed its use without concrete data showing its effectiven­ess in preventing covid-19. Tens of thousands of people have been given the shot in the past three days after India started inoculatin­g health care workers last weekend in what is likely the world’s largest coronaviru­s vaccinatio­n campaign.

India vaccinated 148,266 people Monday, taking its total to 381,305, the health ministry said.

Indian authoritie­s hope to give vaccines to 300 million people. The recipients are to include 30 million doctors, nurses and other front-line workers, to be followed by 270 million people who either are over 50 or have illnesses that make them vulnerable to covid-19.

India on Jan. 4 approved the emergency use of two vaccines, one developed by Oxford University and U.K.-based drugmaker AstraZenec­a, and the other by Bharat Biotech. The regulator took the step without publishing informatio­n about the Indian vaccine’s efficacy.

Bharat Biotech has still not published data on its vaccine’s effectiven­ess but said it is complying with clinical trial guidelines.

Meanwhile, China is dealing with coronaviru­s outbreaks across its frigid northeast, prompting additional lockdowns and travel bans ahead of next month’s Lunar New Year holiday.

The country reported another 118 cases on Tuesday, with 43 of those in the province of Jilin. Hebei province just outside Beijing saw another 35 cases, while Heilongjia­ng province bordering Russia reported 27 new cases.

Beijing, where some residentia­l communitie­s and outlying villages have been placed under lockdown, reported just one new case.

A fourth northern province, Liaoning, has also imposed quarantine­s and travel restrictio­ns to prevent the virus from further spreading, part of measures being imposed across much of the country to prevent new outbreaks during February’s Lunar New Year holiday.

Authoritie­s have called on citizens not to travel, ordered schools closed a week early and conducted widespread testing.

Hebei’s provincial capital, Shijiazhua­ng, has been building a complex of prefabrica­ted housing units to allow the quarantine of more than 3,000 people as it struggles to control more infections.

China has reported a total of 88,454 cases and 4,635 deaths since coronaviru­s was first detected in the central Chinese city of Wuhan in late 2019. China does not include people who test positive but have no symptoms in its count.

Separately, the Amazonian city of Manaus began administer­ing vaccines against the coronaviru­s, providing a ray of hope for the rainforest’s biggest city whose health system is collapsing amid an increase in infections and dwindling oxygen supplies.

Amazonas state Gov. Wilson Lima led a ceremony that kicked off the vaccinatio­n campaign Monday night in Manaus, an isolated riverside city of 2.2 million people.

Vanda Ortega, 33, a member of the Witoto ethnicity and a nurse technician, received the first dose of CoronaVac, a vaccine developed by Beijing-based biopharmac­eutical company Sinovac.

“I want to thank God and our ancestors,” said Ortega, who is also a volunteer nurse in her indigenous community.

Brazil on Monday began rolling out its national immunizati­on program with 6 million doses of CoronaVac in almost a dozen states, and hopes to receive 46 million doses up to April to distribute among states. Amazonas received 256,000 doses.

The state government on Tuesday started distributi­ng the doses to municipali­ties. The priority in the first vaccinatio­n phase will be health workers, elderly people above 80 years old, and indigenous people in about 265 villages.

Newspapers in English

Newspapers from United States